11 – 20 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Mortality Rate by Diagnosis in ANCA-Associated Vasculitis Across FAIRVASC Registries
(2024) p.187-187
- Contribution to conference › Abstract
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
(2024) p.191-191
- Contribution to conference › Abstract
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
- Contribution to journal › Article
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
- Contribution to journal › Article
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
- Contribution to journal › Article
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
- Contribution to journal › Article
-
Mark
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?
- Contribution to journal › Scientific review
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
- Contribution to journal › Article
- 2023
-
Mark
High risk of stroke in ANCA-Associated vasculitis-a population-based study
- Contribution to journal › Article
-
Mark
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis : A Multinational Retrospective Study
- Contribution to journal › Article
